Health Canada Orders Backup to EpiPen Amid Shortages

CBJ — American epinephrine auto-injectors ordered by Health Canada as an emergency backup amid an ongoing EpiPen shortage from Pfizer have been priced at $170 each by manufacturer Kaleo Pharmaceuticals.

For the past three years Pfizer has had the market cornered in Canada with its EpiPen, a life-saving devices for people who have an anaphylactic reaction to allergies. Many schools are equipped with them for children who may be in need.

However, Health Canada made the decision to reach out to Kaleo due to repeated shortages of the EpiPen from Pfizer.

he devices have been approved by the U.S. Food and Drug Administration, and will be available in Canadian pharmacies by this Friday, September 7.